STOCK TITAN

Cambridge Acquisition Unit (CAQUU) 8-K Filings

CAQUU NASDAQ

Here are the 8-K filings from Cambridge Acquisition Corp. Unit (CAQUU) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

An 8-K covers material events a company has to report between its quarterly reports, so if you follow CAQUU and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CAQUU filings page.

Rhea-AI Summary

Cambridge Acquisition Corp. is allowing its SPAC units to begin separate trading. Starting March 30, 2026, investors who hold units trading under the symbol CAQUU may elect to split them into Class A ordinary shares and redeemable warrants.

The Class A ordinary shares will trade on the Nasdaq Global Market under the symbol CAQ, and the warrants will trade under CAQUW. Each whole warrant entitles the holder to buy one Class A ordinary share at $11.50 per share, and only whole warrants, not fractional ones, will trade.

Units that are not separated will continue to trade under CAQUU, so investors can choose whether to keep the bundled security or hold the shares and warrants independently.

Rhea-AI Summary

Cambridge Acquisition Corp., a Cayman Islands blank check company, completed its initial public offering on February 9, 2026. The IPO comprised 23,000,000 units at $10.00 per unit, including full exercise of the over-allotment, for $230,000,000 in gross proceeds.

Each unit contains one Class A ordinary share and one-third of a redeemable warrant, with each whole warrant exercisable at $11.50 per share. The sponsor simultaneously bought 495,500 private units for $4,955,000. In total, $230,000,000 was placed in a U.S.-based trust account for a future business combination.

Rhea-AI Summary

Cambridge Acquisition Corp., a newly formed SPAC, completed its initial public offering of 23,000,000 units at $10.00 per unit, generating $230,000,000 in gross proceeds. Each unit includes one Class A ordinary share and one-third of a redeemable warrant exercisable at $11.50 per share.

The company simultaneously sold 495,500 private units to its sponsor at $10.00 per unit for $4,955,000. As of February 9, 2026, $230,000,000, including $8,050,000 in deferred underwriting commissions, was placed in a trust account for the benefit of public shareholders.